Literature DB >> 32226256

The Hemolyzed Sample: To Analyse Or Not To Analyse.

Seema Bhargava1, Parul Singla1, Anjali Manocha1, Mamta Kankra1, Anisha Sharma1, Ashok Ahirwar1, Rachna Ralhan1, Udhavananda Thapliyal1, Preet Mehra1.   

Abstract

Preanalytical errors constitute about 40-65% of laboratory errors, of which 60% are due to hemolysis. This leads to imprecise reporting and misinterpretation of the actual concentration of analytes. Hence the aim of this study was to estimate the extent of different degrees of interference by visible hemolysis. 25 hemolysed samples along with their fresh unhemolysed sample were studied. Hemolyzed serum was mixed with unhemolyzed serum in predefined serial ratios from 100%, 70%, 50%, 30% and 10% to achieve different grades of hemolysis. Each dilution was analysed for BUN, creatinine, uric acid, phosphorus, Na, K, total protein, amylase, lipase, LDH, tacrolimus and methotrexate. Percentage difference of each dilution of the hemolyzed sample as compared to the unhemolyzed sample was calculated and considered acceptable only if less than TEa. It was observed that Percentage difference of BUN, creatinine, amylase and lipase in all dilutions of hemolyzed samples were within TEa while phosphorus, Na, K, total protein and LDH were beyond the acceptance criteria. Hence It was concluded that it may be safe to analyse a hemolysed sample for BUN, creatinine, amylase, lipase, tacrolimus and methotrexate while uric acid may be estimated in a moderately hemolysed sample. Phosphorus, sodium, potassium, total protein and LDH must never be analyzed in any hemolysed sample. © Association of Clinical Biochemists of India 2019.

Entities:  

Keywords:  Hemolysis; Methotrexate; Preanalytical error; Tacrolimus; Total allowable error TEa

Year:  2019        PMID: 32226256      PMCID: PMC7093627          DOI: 10.1007/s12291-019-00821-4

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  9 in total

1.  [ENZYMATIC UREA DETERMINATION IN THE BLOOD AND SERUM IN THE WARBURG OPTICAL TEST].

Authors:  H TALKE; G E SCHUBERT
Journal:  Klin Wochenschr       Date:  1965-02-01

2.  Mistakes in a stat laboratory: types and frequency.

Authors:  M Plebani; P Carraro
Journal:  Clin Chem       Date:  1997-08       Impact factor: 8.327

3.  Practical recommendations for managing hemolyzed samples in clinical chemistry testing.

Authors:  Giuseppe Lippi; Janne Cadamuro; Alexander von Meyer; Ana-Maria Simundic
Journal:  Clin Chem Lab Med       Date:  2018-04-25       Impact factor: 3.694

4.  The influence of bilirubin, haemolysis and turbidity on 20 analytical tests performed on automatic analysers. Results of an interlaboratory study.

Authors:  D Grafmeyer; M Bondon; M Manchon; P Levillain
Journal:  Eur J Clin Chem Clin Biochem       Date:  1995-01

5.  Interference testing.

Authors:  Goce Dimeski
Journal:  Clin Biochem Rev       Date:  2008-08

6.  Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine.

Authors:  P Fossati; L Prencipe; G Berti
Journal:  Clin Chem       Date:  1980-02       Impact factor: 8.327

Review 7.  Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories.

Authors:  Giuseppe Lippi; Norbert Blanckaert; Pierangelo Bonini; Sol Green; Steve Kitchen; Vladimir Palicka; Anne J Vassault; Mario Plebani
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

8.  Effect of in vitro hemolysis on chemical values for serum.

Authors:  J J Frank; E W Bermes; M J Bickel; B F Watkins
Journal:  Clin Chem       Date:  1978-11       Impact factor: 8.327

9.  Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs.

Authors:  Jaynish S Shah; Patsy S Soon; Deborah J Marsh
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

  9 in total
  1 in total

1.  The effect of hemolysis on quality control metrics for noninvasive prenatal testing.

Authors:  Yaya Guo; Dandan Yu; Kaisu Zhou; Jie Wang; Dongzhu Lei; Zhenpeng Xu; Weijiang Tang; Miaofeng Wu; Xingxing Fang; Jiankun Shen; Zhiyu Peng; Jiale Xiang
Journal:  BMC Med Genomics       Date:  2022-06-04       Impact factor: 3.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.